• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

370
65
48
46
19

COUNTRY

45
12
5
5
5

PRICE

296
549
992
1,428

PUBLISHED

95
127
485
1,428

PRODUCT TYPE

1,333
67
17
11

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Mild Cognitive Impairment - Pipeline Review, H2 2014

Mild Cognitive Impairment - Pipeline Review, H2 2014 Summary This, ‘Mild Cognitive Impairment - Pipeline Review, H2 2014’, provides an overview of the Mild Cognitive Impairment’s therapeutic pipeline. This...

October 2014
FROM

Smoking Cessation - Pipeline Review, H2 2014

Smoking Cessation - Pipeline Review, H2 2014 Summary This, ‘Smoking Cessation - Pipeline Review, H2 2014’, provides an overview of the Smoking Cessation’s therapeutic pipeline. This report provides...

October 2014
FROM

Ischemic Stroke - Pipeline Review, H2 2014

Ischemic Stroke - Pipeline Review, H2 2014 Summary This, ‘Ischemic Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014 Summary This, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014’, provides an overview of the Post-Traumatic Stress...

October 2014
FROM

Fibromyalgia - Pipeline Review, H2 2014

Fibromyalgia - Pipeline Review, H2 2014 Summary This, ‘Fibromyalgia - Pipeline Review, H2 2014’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Schizophrenia - Pipeline Review, H2 2014

Schizophrenia - Pipeline Review, H2 2014 Summary This, ‘Schizophrenia - Pipeline Review, H2 2014’, provides an overview of the Schizophrenia’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Restless Legs Syndrome - Pipeline Review, H2 2014

Restless Legs Syndrome - Pipeline Review, H2 2014 Summary This, ‘Restless Legs Syndrome - Pipeline Review, H2 2014’, provides an overview of the Restless Legs Syndrome’s therapeutic pipeline. This...

October 2014
FROM

Spasticity - Pipeline Review, H2 2014

Spasticity - Pipeline Review, H2 2014 Summary This, ‘Spasticity - Pipeline Review, H2 2014’, provides an overview of the Spasticity’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Spinal Stenosis - Pipeline Review, H2 2014

Spinal Stenosis - Pipeline Review, H2 2014 Summary This, ‘Spinal Stenosis - Pipeline Review, H2 2014’, provides an overview of the Spinal Stenosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Parkinson's Disease - Pipeline Review, H2 2014

Parkinson's Disease - Pipeline Review, H2 2014 Summary This, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Anesthetic Effect - Pipeline Review, H2 2014

Anesthetic Effect - Pipeline Review, H2 2014 Summary This, ‘Anesthetic Effect - Pipeline Review, H2 2014’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides...

October 2014
FROM

Stroke - Pipeline Review, H2 2014

Stroke - Pipeline Review, H2 2014 Summary This, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

October 2014
FROM

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic...

October 2014
FROM
Imitrex-Drug Insights,2014 Imitrex-Drug Insights,2014 - Product Thumbnail Image

Imitrex-Drug Insights,2014

“Imitrex - Drug Insights, 2014” provides Imitrex marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

November 2014
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

October 2014
FROM

Partial Seizure - Pipeline Review, H2 2014

Partial Seizure - Pipeline Review, H2 2014 Summary This, ‘Partial Seizure - Pipeline Review, H2 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing...

September 2014
FROM

Autism - Pipeline Review, H2 2014

Autism - Pipeline Review, H2 2014 Summary This, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM
Loading Indicator

Our Clients

Our clients' logos